The digital healthcare company recorded a 90% improvement in EBITDA compared to FY23 and a 22% growth in revenue; the company’s top priority in FY25 is to grow profitably and build innovative products that continue to improve health outcomes.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.